Form D · Biotechnology

Adjuvance Technologies Inc.

Lincoln, NE · CIK 0001652786

Offering snapshot reported Nov 22, 2019 · SEC filing

Reported sold
$10.7M
Offering amount: $24.7M
Investors reported
28
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 29, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.33M$10.7MSep 24, 2019: $10,657,192.00Sep 24, 2019Nov 22, 2019: $10,657,192.00Nov 22, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 22, 2019Amendment$10,657,192$0vs Sep 24, 201928SEC filing
Sep 24, 2019Initial$10,657,192No comparison28SEC filing
Nov 14, 2016Amendment$2,717,694$1,717,694vs Sep 22, 201515SEC filing
Sep 22, 2015Initial$1,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-349477

Source: Form D, filed Nov 22, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Isaac Cheng Director
Stephen Dilly Director
Christopher Frigon Executive
John Gallo Director
Jeffrey Gardner Executive
Mary Gin Director
Ken Kelley Director
Phil Livingston Director
J. Tyler Martin Director, Executive
Tyler Martin Director, Executive
Gregory Poland Director
Govind Ragupathi Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1225 L Street, Suite 600
Lincoln, NE, 68508